Literature DB >> 29774583

Intravenous immunoglobulins in dermatology. Part 1: biological mechanisms and methods of administration.

E Forbat1, F R Ali2, F Al-Niaimi2.   

Abstract

Intravenous immunoglobulin (IVIg) is a solution of human IgG, salt, sugars and solvents, which is used to treat a multitude of diseases. Although IVIg has been known to treat many diseases safely and successfully, there are relatively few supporting randomized controlled trials. In this article, we review the biological mechanisms of IVIg in dermatological disorders and the practicalities of its use, including its mechanism of action, dosing, availability, costs and adverse effects.
© 2018 British Association of Dermatologists.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29774583     DOI: 10.1111/ced.13553

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

1.  Low-dose subcutaneous immunoglobulin is an effective treatment for autoimmune bullous skin disorders: A case report.

Authors:  Erin Streu; Marni C Wiseman; James B Johnston
Journal:  SAGE Open Med Case Rep       Date:  2020-01-21

Review 2.  Sialylated immunoglobulin G: a promising diagnostic and therapeutic strategy for autoimmune diseases.

Authors:  Danqi Li; Yuchen Lou; Yamin Zhang; Si Liu; Jun Li; Juan Tao
Journal:  Theranostics       Date:  2021-03-13       Impact factor: 11.556

Review 3.  Pemphigus Vulgaris: Present and Future Therapeutic Strategies.

Authors:  Dario Didona; Giovanni Paolino; Giovanni Di Zenzo; Biagio Didona; Riccardo Pampena; Matteo Riccardo Di Nicola; Santo Raffaele Mercuri
Journal:  Dermatol Pract Concept       Date:  2022-01-01

4.  Systems biology and artificial intelligence analysis highlights the pleiotropic effect of IVIg therapy in autoimmune diseases with a predominant role on B cells and complement system.

Authors:  Cristina Segú-Vergés; Silvia Caño; Elisabeth Calderón-Gómez; Helena Bartra; Teresa Sardon; Srini Kaveri; José Terencio
Journal:  Front Immunol       Date:  2022-09-30       Impact factor: 8.786

5.  Immunoglobulins with Non-Canonical Functions in Inflammatory and Autoimmune Disease States.

Authors:  Evgeny A Ermakov; Georgy A Nevinsky; Valentina N Buneva
Journal:  Int J Mol Sci       Date:  2020-07-29       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.